Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.9K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical recommendations for infectious prophylaxis and vaccination in multiple myeloma patients.

Frontiers in medicine·2026
Same author

Translational insights into extracellular vesicles in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Integrating Participatory Social Innovation Into Requirements Engineering for AI Health Care Solutions: Case Study.

Journal of medical Internet research·2026
Same author

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Plasma proteomic signatures associated with abdominal aortic aneurysm presence, growth, and risk of mortality.

Scientific reports·2026
Same author

How Laboratory Innovations Are Shaping the Future of Multiple Myeloma Care.

Cancers·2026

Related Experiment Video

Updated: Sep 3, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

7.0K

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment.

Raquel Lopes1,2, Joana Caetano1,3,4, Filipa Barahona1,4

  • 1Myeloma Lymphoma Research Group, Champalimaud Experimental Clinical Research Programme, Champalimaud Foundation, Lisbon, Portugal.

Frontiers in Immunology
|July 25, 2022
PubMed
Summary

Multiple myeloma (MM) extracellular vesicles (EVs) remodel the bone marrow immune microenvironment. MM-derived EVs promote immune suppression, highlighting their role in cancer progression.

Keywords:
MOPC315.BM cellsextracellular vesiclesmouse modelmultiple myelomatumor immune microenvironment

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.8K

Related Experiment Videos

Last Updated: Sep 3, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

7.0K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.8K

Area of Science:

  • Immunology
  • Oncology
  • Cancer Biology

Background:

  • Multiple myeloma (MM) is a hematological cancer marked by plasma cell proliferation in the bone marrow (BM).
  • A permissive BM microenvironment is a hallmark of MM.
  • Extracellular vesicles (EVs) from myeloma cells mediate communication with immune cells, influencing MM pathogenesis.

Purpose of the Study:

  • To investigate immune alterations in the BM microenvironment induced by MM-derived EVs.
  • To understand the role of MM-derived EV protein content in immune niche remodeling.

Main Methods:

  • Inoculation of immunocompetent BALB/cByJ mice with the MOPC315.BM myeloma cell line.
  • Characterization of the BM microenvironment, including lymphocyte activation and suppressive markers (e.g., granzyme B, PD-1).
  • Pre-conditioning of animals with MOPC315.BM-derived EVs before tumor cell transplantation.

Main Results:

  • Tumor establishment led to the expression of activation and suppressive markers on BM lymphocytes.
  • Pre-conditioning with MM-derived EVs did not alter the disease phenotype but induced BM immune suppression.
  • An increase in PD-1 expression on CD4+ T cells was observed following EV conditioning.

Conclusions:

  • MM-derived EVs, particularly their protein content, contribute to immune niche remodeling.
  • These EVs promote immune suppression within the BM microenvironment.
  • Further research is needed to elucidate the mechanisms by which MM impacts the immune microenvironment via EVs.